Form 4: Clorox Director Christopher J. Williams Acquires Shares and Deferred Stock Units
SEC Form 4 Filing
Director Christopher J. Williams acquired Clorox shares and deferred stock units in lieu of director's fees, according to a recent SEC filing.
Summary
- On June 28, 2024, Christopher J. Williams, a director of Clorox, acquired 238 shares of Clorox common stock at a price of $136.47 per share.
- These shares were received in lieu of a quarterly director's fee.
- Following the transaction, Williams directly owns 450 shares of Clorox common stock.
- On May 10, 2024, Williams also received 141.1188 deferred stock units, which will be settled in Clorox stock upon retirement or termination of service as a director.
- The price of the derivative security is $0.0000.
- Following the transaction, Williams directly owns 16,998.9404 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as the filing simply reports routine transactions related to director compensation.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
- The receipt of deferred stock units aligns the director's interests with the long-term success of the company.
Future Outlook
The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or termination of service.
Industry Context
Directors receiving stock in lieu of fees is a fairly common practice to align interests with shareholders, particularly in large, publicly traded companies like Clorox.
Comparison to Industry Standards
- Stock ownership by directors is a common practice in publicly traded companies.
- Companies like Procter & Gamble (PG) and Unilever (UL) also have similar compensation structures for their board members, often including stock options and deferred stock units.
- The specific amounts and terms can vary based on company size, performance, and industry norms.
Related Party Transactions
- The receipt of stock and deferred stock units in lieu of director's fees constitutes a related party transaction.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Receipt of Deferred Stock Units |
| 06/28/2024 | Acquisition of Common Stock |
| 07/02/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.